ZIOPHARM Oncology

ZIOPHARM Oncology, Inc., is a biopharmaceutical company focused on the discovery and development of new cancer therapies. We are applying the latest technologies in cancer research to develop safer, more precise therapeutics to improve care and quality of life for patients.
Type
Public
HQ
Boston, US
Employees
28 (est)
ZIOPHARM Oncology is headquartered in Boston, US

Key People at ZIOPHARM Oncology

Jonathan Lewis

Jonathan Lewis

CEO
Caesar J. Belbel

Caesar J. Belbel

CLO

ZIOPHARM Oncology Locations

Boston, US

ZIOPHARM Oncology Metrics

ZIOPHARM Oncology Summary

Market capitalization

$878 M

Closing share price

$6.87
ZIOPHARM Oncology's latest market capitalization is $878 M.

ZIOPHARM Oncology Market Value History

24% of current employees of ZIOPHARM Oncology are female and 76% are male.

ZIOPHARM Oncology Company Life

You may also be interested in